Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Глаукомы вторичные

Список литературы

  1. Shaarawy T.M., Sherwood M.B., Hitchings R.A., Crowston J.G. Glaucoma: medical diagnosis and therapy, 2-nd (Vol.1). London: Elsevier, 2015: 1201.
  2. Национальное руководство по глаукоме для практикующих врачей. Изд. 4-е, испр. и доп. / Под ред. Е.А. Егорова, В.П. Еричева. М.: ГЭОТАР-Медиа, 2019: 384.
  3. Basic and Clinical Science Course. Section 10. Glaucoma / Ed. C.A. Girkin. San Francisco: AAO, 2018: 262.
  4. Charteris D.G., Barton K., McCartney A.C., Lightman S.L. CD4+ lymphocyte involvement in ocular Behcet's disease. Autoimmunity 1992; 12(3): 201-6.
  5. Clark A.F., Wilson K., de Kater A.W., Allingham R.R., McCartney M.D. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest Ophthalmol Vis Sci 1995; 36(2): 478-89.
  6. Ladas J.G., Yu F., Loo R., Davis J.L., Coleman A.L., Levinson R.D., et al. Relationship between aqueous humor protein level and outflow facility in patients with uveitis. Invest Ophthalmol Vis Sci 2001; 42(11): 2584-8.
  7. Planck S.R., Huang X.N., Robertson J.E., Rosenbaum J.T. Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Invest Ophthalmol Vis Sci 1994; 35(3): 924-30.
  8. Herbert H.M., Viswanathan A., Jackson H., Lightman S.L. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma 2004; 13(2): 96-9.
  9. Merayo-Lloves J., Power W.J., Rodriguez A., Pedroza-Seres M., Foster C.S. Secondary glaucoma in patients with uveitis. Ophthalmologica 1999; 213(5): 300-4.
  10. Takahashi T., Ohtani S., Miyata K., Miyata N., Shirato S., Mochizuki M. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol 2002; 46(5): 556-62.
  11. Neri P., Azuara-Blanco A., Forrester J.V. Incidence of glaucoma in patients with uveitis. J Glaucoma 2004; 13(6): 461-5.
  12. de Boer J., Wulffraat N., Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol 2003; 87(7): 879-84.
  13. Kanski J.J., Shun-Shin G.A. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology 1984; 91(10): 1247-52.
  14. Barton K., Pavesio C.E., Towler H.M., Lightman S. Uveitis presenting de novo in the elderly. Eye (Lond) 1994; 8 ( Pt 3)(288-91.
  15. Panek W.C., Holland G.N., Lee D.A., Christensen R.E. Glaucoma in patients with uveitis. Br J Ophthalmol 1990; 74(4): 223-7.
  16. Нестеров А.П., Бунин А.Я. О новой классификации первичной глаукомы. Вестник офтальмологии. 1977; 5; 38-42.
  17. Foster P.J., Buhrmann R., Quigley H.A., Johnson G.J. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 2002; 86(2): 238-42.
  18. Glaucoma: diagnosis and management. Methods, evidence and recommendations. London: NICE, 2017: 324.
  19. International Council of Ophthalmology Guidelines for Glaucoma Eye Care / ed. N. Gupta et al., ICO, San Francisco, 2015:22
  20. Панова И.Е., Дроздова Е.А., Авдеева О.Н. Глава 28. Увеиты. В кн.: Офтальмология: национальное руководство / под ред. С.Э. Аветисова, Е.А. Егорова, Л.К. Мошетовой, В.В. Нероева, Х.П. Тахчиди. М.: ГЭОТАР-Медиа, 2018. - C. 507-560.
  21. Jabs D.A., Nussenblatt R.B., Rosenbaum J.T., Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140(3): 509-16.
  22. Foster C., Vitale A. Diagnosis and Treatment of Uveitis. New Delhi, Jaypee Brothers Medical Publishers; 2nd ed, 2013. – 1276 p.
  23. Gupta A. Herbort C.P., Khairallah M. Uveitis. Text and Imaging. New Delhi, 2009. – 830 p.
  24. Nussenblatt R.B., Whitcup S.M. Uveitis: fundamentals and clinical practice, 4rd ed. Philadelphia: Mosby, 2010. – 433 p.
  25. Кацнельсон Л.А., Танковский В.Э. Увеиты. М.: 4-й филиал Воениздата, 2003. – 286 c.
  26. Панова И.Е., Дроздова Е.А. Увеиты: руководство для врачей. М.: ООО «Издательство «Медицинское информационное агентство», 2014. – 144 c.
  27. Устинова Е.И. Эндогенные увеиты (избранные лекции для врачей-офтальмологов). СПб: Эко-Вектор, 2017. – 202 c.
  28. Астахов Ю.С., Кузнецова Т.И., Хрипун К.В., Коненкова Я.С., Белозерова Е.В. Перспективы диагностики и эффективность лечения болезни Фогта–Коянаги–Харада. Офтальмологические ведомости. 2014; 7 (3): 84-92 (https://doi.org/10.17816/OV2014384-92).
  29. Boyd S.R., Young S., Lightman S. Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol 2001; 46(3): 209-33.
  30. de Smet M.D., Taylor S.R., Bodaghi B., Miserocchi E., Murray P.I., Pleyer U., et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res 2011; 30(6): 452-70.
  31. Егоров Е.А., Нестеров А.П. Первичная открытоугольная глаукома / в кн. Офтальмология. Национальное руководство под. ред. С.Э. Аветисова, Е.А. Егорова, Л.К. Моше-товой, Х.П. Тахчиди. М.: ГЭОТАР-Медиа, 2018: 713-726.
  32. Branson S.V., McClafferty B.R., Kurup S.K. Vitrectomy for Epiretinal Membranes and Macular Holes in Uveitis Patients. J Ocul Pharmacol Ther 2017; 33(4): 298-303.
  33. Grodum K., Heijl A., Bengtsson B. Refractive error and glaucoma. Acta Ophthalmol Scand 2001; 79(6): 560-6.
  34. Mitchell P., Hourihan F., Sandbach J., Wang J.J. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology 1999; 106(10): 2010-5.
  35. Perera S.A., Wong T.Y., Tay W.T., Foster P.J., Saw S.M., Aung T. Refractive error, axial dimensions, and primary open-angle glaucoma: the Singapore Malay Eye Study. Arch Ophthalmol 2010; 128(7): 900-5.
  36. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol 2000; 130(4): 429-40.
  37. Нестеров А.П. Глаукома. М.: Медицинское информационное агентство, 2008: 360.
  38. Антонов А.А., Карлова Е.В., Брежнев А.Ю., Дорофеев Д.А. Современное состояние офтальмотонометрии. Вестник офтальмологии. 2020;136(6):100-107.
  39. Балашевич Л.И., Качанов А.Б., Никулин С.А. и др. Влияние толщины роговицы на пневмотонометрические показатели внутриглазного давления. Офтальмохирургия. 2005; 1: 31-33.
  40. Cook J.A., Botello A.P., Elders A., Fathi Ali A., Azuara-Blanco A., Fraser C., et al. Systematic review of the agreement of tonometers with Goldmann applanation tonometry. Ophthalmology 2012; 119(8): 1552-7.
  41. Quigley H.A., Dunkelberger G.R., Green W.R. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989; 107(5): 453-64.
  42. Sagri D., Losche C.C., Bestges B.B., Krummenauer F. Is There Really Agreement between Rebound and Goldmann Applanation Tonometry Methods? Results of a Systematic Review of the Period 01/2005 to 08/2014. Klin Monbl Augenheilkd 2015; 232(7): 850-7.
  43. Абышева Л.Д., Авдеев Р.В., Александров А.С. и др. Оптимальные характеристики верхней границы офтальмотонуса у пациентов с развитой стадией первичной открыто-угольной глаукомы с точки зрения доказательной медицины. Клиническая офтальмоло-гия. 2015; 3: 111-123.
  44. Bengtsson B., Leske M.C., Hyman L., Heijl A., Early Manifest Glaucoma Trial G. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 2007; 114(2): 205-9.
  45. Kniestedt C., Punjabi O., Lin S., Stamper R.L. Tonometry through the ages. Surv Ophthalmol 2008; 53(6): 568-91.
  46. Konstas A.G., Kahook M.Y., Araie M., Katsanos A., Quaranta L., Rossetti L., et al. Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment. Adv Ther 2018; 35(11): 1775-804.
  47. Prata T.S., De Moraes C.G., Kanadani F.N., Ritch R., Paranhos A., Jr. Posture-induced intraocular pressure changes: considerations regarding body position in glaucoma patients. Surv Ophthalmol 2010; 55(5): 445-53.
  48. Sacca S.C., Rolando M., Marletta A., Macri A., Cerqueti P., Ciurlo G. Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects. Ophthalmologica 1998; 212(2): 115-9.
  49. European Glaucoma Society Terminology and Guidelines for Glaucoma (5th Edition). Savona: PubliComm, 2020: 172.
  50. Congdon N.G., Spaeth G.L., Augsburger J., Klancnik J., Jr., Patel K., Hunter D.G. A proposed simple method for measurement in the anterior chamber angle: biometric gonioscopy. Ophthalmology 1999; 106(11): 2161-7.
  51. Олвэрд У.Л.М., Лонгмуа Р.А. Атлас по гониоскопии (пер. с англ.) / под ред. Т.В. Соколовской. М.: «ГЭОТАР-Медиа», 2010: 120.
  52. Шульпина Н.Б. Биомикроскопия глаза. М.: Медицина. 1974: 264.
  53. Spaeth G.L. The normal development of the human anterior chamber angle: a new system of descriptive grading. Trans Ophthalmol Soc U K (1962) 1971; 91(709-39.
  54. Gonioscopy anatomy of the angle of the anterior chamber of the eye. In. SRe, ed. In: Shaffer R.N. Stereoscopic manual of gonioscopy. St. Louis, Mosby, 1962: 92.
  55. Sakata L.M., Lavanya R., Friedman D.S., Aung H.T., Gao H., Kumar R.S., et al. Comparison of gonioscopy and anterior segment ocular coherence tomography in detecting angle closure in different quadrants of the anterior chamber angle. Ophthalmology 2008; 115(5): 769-74.
  56. Diagnosis of Primary Open Angle Glaucoma. Consensus Series - 10 / Ed. R.N. Weinreb., D. Garway-Heath, C. Leung, F. Medeiros, J. Liebmann. Amsterdam: Kugler Publications, 2017: 234.
  57. Jonas J.B., Gusek G.C., Naumann G.O. Optic disc, cup and neuroretinal rim size, configuration and correlations in normal eyes. Invest Ophthalmol Vis Sci 1988; 29(7): 1151-8.
  58. Morgan J.E., Bourtsoukli I., Rajkumar K.N., Ansari E., Cunliffe I.A., North R.V., et al. The accuracy of the inferior>superior>nasal>temporal neuroretinal rim area rule for diagnosing glaucomatous optic disc damage. Ophthalmology 2012; 119(4): 723-30.
  59. Glaucoma Imaging / Eds. Iester M., Garway-Heath D., Lemij H. Savona: PubliComm, 2017: 144.
  60. Егоров Е.А. Фото- и стереофотографические методики изучения глазного дна. Военно-медицинский журнал. 1977; 5: 46-47.
  61. Куроедов А.В., Городничий В.В., Огородникова В.Ю. и др. Офтальмоскопическая характеристика изменений диска зрительного нерва и слоя нервных волокон при глаукоме (пособие для врачей). М.: «Дом печати «Столичный бизнес», 2011: 48.
  62. Harizman N., Oliveira C., Chiang A., Tello C., Marmor M., Ritch R., et al. The ISNT rule and differentiation of normal from glaucomatous eyes. Arch Ophthalmol 2006; 124(11): 1579-83.
  63. Ernest P.J., Viechtbauer W., Schouten J.S., Beckers H.J., Hendrikse F., Prins M.H., et al. The influence of the assessment method on the incidence of visual field progression in glaucoma: a network meta-analysis. Acta Ophthalmol 2012; 90(1): 10-9.
  64. Yanagisawa M., Murata H., Matsuura M., Fujino Y., Hirasawa K., Asaoka R. Investigating the structure-function relationship using Goldmann V standard automated perimetry where glaucomatous damage is advanced. Ophthalmic Physiol Opt 2019; 39(6): 441-50.
  65. Intraocular Pressure. Consensus Series - 4. / Ed. R.N. Weinreb, J.D. Brandt, D. Garway-Heath, F. Medeiros. Amsterdam: Kugler Publications, 2007: 128.
  66. Аветисов С.Э., Бубнова И.А., Антонов А.А. Биомеханические свойства роговицы: клиническое значение, методы исследования, возможности систематизации подходов к изучению. Вестник офтальмологии. 2010; 126(6): 3-7.
  67. Belovay G.W., Goldberg I. The thick and thin of the central corneal thickness in glaucoma. Eye (Lond) 2018; 32(5): 915-23.
  68. Doughty M.J., Zaman M.L. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol 2000; 44(5): 367-408.
  69. Дроздова Е.А., Ильинская Е.В. Диагностические возможности исследования оболочек глаза при увеитах. Медицинский вестник Башкортостана. 2018; Т.1. №1(73):51-54.
  70. Kansal V., Armstrong J.J., Pintwala R., Hutnik C. Optical coherence tomography for glaucoma diagnosis: An evidence based meta-analysis. PLoS One 2018; 13(1): e0190621.
  71. Regatieri C.V., Alwassia A., Zhang J.Y., Vora R., Duker J.S. Use of optical coherence tomography in the diagnosis and management of uveitis. Int Ophthalmol Clin 2012; 52(4): 33-43.
  72. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998; 126(4): 498-505.
  73. Авдеев Р.В., Александров А.С., Бакунина Н.А. и др. Сопоставление режимов лечения больных с первичной открытоугольной глаукомой с характеристиками прогрессирования заболевания. Часть 1. Состояние показателей офтальмотонуса. Национальный журнал глаукома. 2018; 17(1): 14-28.
  74. Heijl A., Leske M.C., Bengtsson B., Hyman L., Bengtsson B., Hussein M., et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120(10): 1268-79.
  75. Lichter P.R., Musch D.C., Gillespie B.W., Guire K.E., Janz N.K., Wren P.A., et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108(11): 1943-53.
  76. Leske M.C., Wu S.Y., Hennis A., Honkanen R., Nemesure B., Group B.E.S. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology 2008; 115(1): 85-93.
  77. Chauhan B.C., Mikelberg F.S., Artes P.H., Balazsi A.G., LeBlanc R.P., Lesk M.R., et al. Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change. Arch Ophthalmol 2010; 128(10): 1249-55.
  78. Drance S., Anderson D.R., Schulzer M., Collaborative Normal-Tension Glaucoma Study G. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 2001; 131(6): 699-708.
  79. Kobelt G. Comparative data for all countries. In: Primary open-angle glaucoma. Differ-ences in international treatment patterns and costs. / Eds. Jönsson B., Krieglstein G. Oxford, England: ISIS Medical Media, 1998: 116-126.
  80. Diaconita V., Quinn M., Jamal D., Dishan B., Malvankar-Mehta M.S., Hutnik C. Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis. J Ophthalmol 2018; 2018(3190684.
  81. Musch D.C., Gillespie B.W., Niziol L.M., Lichter P.R., Varma R., Group C.S. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2011; 118(9): 1766-73.
  82. Chiba T., Kashiwagi K., Chiba N., Tsukahara S. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension. Br J Ophthalmol 2006; 90(3): 314-7.
  83. Kashiwagi K., Tsukahara S. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost. Br J Ophthalmol 2003; 87(3): 297-301.
  84. Kiuchi Y., Okada K., Ito N., Hayashida Y., Fukui K., Ohnishi T., et al. Effect of a single drop of latanoprost on intraocular pressure and blood-aqueous barrier permeability in patients with uveitis. Kobe J Med Sci 2002; 48(5-6): 153-9.
  85. Fechtner R.D., Khouri A.S., Zimmerman T.J., Bullock J., Feldman R., Kulkarni P., et al. Anterior uveitis associated with latanoprost. Am J Ophthalmol 1998; 126(1): 37-41.
  86. Schumer R.A., Camras C.B., Mandahl A.K. Putative side effects of prostaglandin analogs. Surv Ophthalmol 2002; 47 Suppl 1(S219.
  87. Smith S.L., Pruitt C.A., Sine C.S., Hudgins A.C., Stewart W.C. Latanoprost 0.005% and anterior segment uveitis. Acta Ophthalmol Scand 1999; 77(6): 668-72.
  88. Ekatomatis P. Herpes simplex dendritic keratitis after treatment with latanoprost for primary open angle glaucoma. Br J Ophthalmol 2001; 85(8): 1008-9.
  89. Kaufman H.E., Varnell E.D., Toshida H., Kanai A., Thompson H.W., Bazan N.G. Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit. Am J Ophthalmol 2001; 131(5): 643-6.
  90. Wand M., Gilbert C.M., Liesegang T.J. Latanoprost and herpes simplex keratitis. Am J Ophthalmol 1999; 127(5): 602-4.
  91. Arcieri E.S., Santana A., Rocha F.N., Guapo G.L., Costa V.P. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial. Arch Ophthalmol 2005; 123(2): 186-92.
  92. Schuman J.S. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2. Ophthalmology 2000; 107(6): 1171-7.
  93. van der Valk R., Webers C.A., Schouten J.S., Zeegers M.P., Hendrikse F., Prins M.H. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 2005; 112(7): 1177-85.
  94. Erb C. Glaucoma and Dry Eye. Bremen: UNI-MED Verlag AG, 2012: 102.
  95. Бржеский В.В. Глаукома и синдром “сухого” глаза. М.: ООО “Компания БОРГЕС”, 2018: 228.
  96. Erb C., Lanzl I., Seidova S.F., Kimmich F. Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension. Adv Ther 2011; 28(7): 575-85.
  97. Cheng J.W., Li Y., Wei R.L. Systematic review of intraocular pressure-lowering effects of adjunctive medications added to latanoprost. Ophthalmic Res 2009; 42(2): 99-105.
  98. Liu A.W., Gan L.Y., Yao X., Zhou J. Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy. Int J Ophthalmol 2016; 9(5): 750-6.
  99. Liu Y., Zhao J., Zhong X., Wei Q., Huang Y. Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or beta-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis. Front Pharmacol 2019; 10(679.
  100. Xing Y., Jiang F.G., Li T. Fixed combination of latanoprost and timolol vs the individual components for primary open angle glaucoma and ocular hypertension: a systematic review and meta-analysis. Int J Ophthalmol 2014; 7(5): 879-90.
  101. Cheng J.W., Cheng S.W., Gao L.D., Lu G.C., Wei R.L. Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis. PLoS One 2012; 7(9): e45079.
  102. Куроедов А.В., Брежнев А.Ю., Ловпаче Д.Н. и соавт. Целесообразность примене-ния дифференцированных («ступенчатых») стартовых подходов к лечению больных с разными стадиями глаукомы. Национальный журнал Глаукома. 2018;17(4):27-54.
  103. Olthoff C.M., Schouten J.S., van de Borne B.W., Webers C.A. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology 2005; 112(6): 953-61.
  104. Medical Treatment of Glaucoma. WGA Consensus Series - 7. / Eds. Weinreb R., Makoto A., Susanna R., Goldberg I., Migdal C., Liebmann J. Kugler Publications, 2010: 309.
  105. Ho J.D., Hu C.C., Lin H.C. Antiglaucoma medications during pregnancy and the risk of low birth weight: a population-based study. Br J Ophthalmol 2009; 93(10): 1283-6.
  106. Murphy C.C., Burnett C.A., Spry P.G., Broadway D.C., Diamond J.P. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2003; 87(10): 1252-7.
  107. Williams I.M., Neerukonda V.K., Stagner A.M. The Histopathology of Two Eyes Enucleated after Continuous Transscleral and Micropulse Transscleral Cyclophotocoagulation for Refractory Secondary Glaucoma. Ocul Oncol Pathol 2022; 8(2): 93-9.
  108. Xia J.L., Ertel M.K., Reddy A.K., Palestine A.G., Stanley A.J., Capitena Young C.E., et al. Outcomes of Micropulse Transscleral Cyclophotocoagulation in Uveitic Glaucoma. Ophthalmol Ther 2024.
  109. Нероев В.В., Киселева О.А., Бессмертный А.М. Основные результаты мультицентрового исследования эпидемиологических особенностей первичной открытоугольной глаукомы в Российской Федерации. Российский офтальмологический журнал. 2013; 6(3): 4-7.
  110. Buck's 2019 ICD-10-CM Physician Edition E-Book, 1st Ed. New York: Saunders, 2019: 1600.
  111. International Statistical Classification of Diseases and Related Health Problems 10th Re-vision (ICD-10). WHO Version for; 2016. URL: https://icd.who.int/browse10/2016/en#/H40-H42 (дата обращения 25.12.2019).
  112. Broadway D.C., Bates A.K., Lightman S.L., Grierson I., Hitchings R.A. The importance of cellular changes in the conjunctiva of patients with uveitic glaucoma undergoing trabeculectomy. Eye (Lond) 1993; 7 ( Pt 4)(495-501.
  113. Broadway D.C., Grierson I., Sturmer J., Hitchings R.A. Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol 1996; 114(3): 262-7.
  114. Glaucoma Surgery. Consensus - 11 / Eds. Weinreb R.N., Ramulu P., Topouzis F., Park K.H., Mansouri K., Lerner S.F. Amsterdam: Kugler Publications, 2019: 512.
  115. Razeghinejad M.R., Fudemberg S.J., Spaeth G.L. The changing conceptual basis of trabeculectomy: a review of past and current surgical techniques. Surv Ophthalmol 2012; 57(1): 1-25.
  116. Ceballos E.M., Beck A.D., Lynn M.J. Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 2002; 11(3): 189-96.
  117. Prata J.A., Jr., Neves R.A., Minckler D.S., Mermoud A., Heuer D.K. Trabeculectomy with mitomycin C in glaucoma associated with uveitis. Ophthalmic Surg 1994; 25(9): 616-20.
  118. Stavrou P., Murray P.I. Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol 1999; 128(4): 434-9.
  119. Towler H.M., Bates A.K., Broadway D.C., Lightman S. Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis. Ocul Immunol Inflamm 1995; 3(3): 163-70.
  120. Wright M.M., McGehee R.F., Pederson J.E. Intraoperative mitomycin-C for glaucoma associated with ocular inflammation. Ophthalmic Surg Lasers 1997; 28(5): 370-6.
  121. Armstrong J.J., Denstedt J.T., Trelford C.B., Li E.A., Hutnik C.M.L. Differential effects of dexamethasone and indomethacin on Tenon's capsule fibroblasts: Implications for glaucoma surgery. Exp Eye Res 2019; 182(65-73).
  122. Cabourne E., Clarke J.C., Schlottmann P.G., Evans J.R. Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. Cochrane Database Syst Rev 2015; 11): CD006259.
  123. Leung D.Y., Tham C.C. Management of bleb complications after trabeculectomy. Semin Ophthalmol 2013; 28(3): 144-56.
  124. Masoumpour M.B., Nowroozzadeh M.H., Razeghinejad M.R. Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries. Open Ophthalmol J 2016; 10(68-85.
  125. Chen H.J., Lin C., Lee C.H., Chen Y.H. Efficacy and Safety of Bevacizumab Combined with Mitomycin C or 5-Fluorouracil in Primary Trabeculectomy: A Meta-Analysis of Randomized Clinical Trials. Ophthalmic Res 2018; 59(3): 155-63.
  126. Cheng J.W., Cheng S.W., Wei R.L., Lu G.C. Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery. Cochrane Database Syst Rev 2016; 1): CD009782.
  127. Петров С.Ю. Современная концепция борьбы с избыточным рубцеванием после фистулизирующей хирургии глаукомы. Противовоспалительные препараты и новые тенденции. Офтальмология. 2017;14(2): 99–105.
  128. Алексеев В.Н., Левко М.А., Хамед С.М., Ессам Т. Хирургическое лечение рефрактерной глаукомы. Офтальмологические ведомости. 2011; 4(3): 65-69.
  129. Алексеев И.Б., Прошина О.И., Шормаз И.Н. и др. Результаты хирургического лече-ния открытоугольной глаукомы у пациентов с артифакией. Практическая медицина. 2017; 1(9) (110): 127-130.
  130. Петров С.Ю., Антонов А.А., Макарова А.С. и др. Возможности пролонгации гипотензивного эффекта трабекулэктомии. Вестн. офтальмологии. 2015;131(1):75-81.
  131. Park I.K., Chun Y.S., Kim K.G., Yang H.K., Hwang J.M. New clinical grading scales and objective measurement for conjunctival injection. Invest Ophthalmol Vis Sci 2013; 54(8): 5249-57.
  132. Araujo S.V., Spaeth G.L., Roth S.M., Starita R.J. A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology 1995; 102(12): 1753-9.
  133. Chen P.P., Weaver Y.K., Budenz D.L., Feuer W.J., Parrish R.K., 2nd. Trabeculectomy function after cataract extraction. Ophthalmology 1998; 105(10): 1928-35.
  134. Федорук Н.А. Современные взгляды на патогенез и лечение неоваскулярной глаукомы. Вестник офтальмологии. 2024; 140(3): 110-6.
  135. John T., Sassani J.W., Eagle R.C., Jr. The myofibroblastic component of rubeosis iridis. Ophthalmology 1983; 90(6): 721-8.
  136. Detorakis E.T., Engstrom R.E., Jr., Wallace R., Straatsma B.R. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma. Ophthalmology 2005; 112(3): 505-10.
  137. Egbert P.R., Donaldson S.S., Moazed K., Rosenthal A.R. Visual results and ocular complications following radiotherapy for retinoblastoma. Arch Ophthalmol 1978; 96(10): 1826-30.
  138. Hirasawa N., Tsuji H., Ishikawa H., Koyama-Ito H., Kamada T., Mizoe J.E., et al. Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2007; 67(2): 538-43.
  139. Matsui N., Kamao T., Azumi A. Case of metastatic intraocular malignant lymphoma with neovascular glaucoma. Nippon Ganka Gakkai Zasshi 2005; 109(7): 434-9.
  140. Yahia S.B., Touffahi S.A., Zeghidi H., Zaouali S., Khairallah M. Ocular neovascularization in a patient with Fanconi anemia. Can J Ophthalmol 2006; 41(6): 778-9.
  141. Telander D.G., Holland G.N., Wax M.B., Van Gelder R.N. Rubeosis and anterior segment ischemia associated with systemic cryoglobulinemia. Am J Ophthalmol 2006; 142(4): 689-90.
  142. Mayer J., Brouillette G., Corriveau L.A. Sarcoidosis and rubeosis iridis. Can J Ophthalmol 1983; 18(4): 197-8.
  143. Mocanu C., Barascu D., Marinescu F., Lacrateanu M., Iliusi F., Simionescu C. Neovascular glaucoma - retrospective study. Oftalmologia 2005; 49(4): 58-65.
  144. Vancea P.P., Abu-Taleb A. Current trends in neovascular glaucoma treatment. Rev Med Chir Soc Med Nat Iasi 2005; 109(2): 264-8.
  145. Липатов Д.В. Диабетическая глаукома. Москва: Медицинское информационное агентство; 2021.
  146. Detry-Morel M. Neovascular glaucoma in the diabetic patient. Bull Soc Belge Ophtalmol 1995; 256(133-41.
  147. Hayreh S.S., Klugman M.R., Podhajsky P., Servais G.E., Perkins E.S. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study. Graefes Arch Clin Exp Ophthalmol 1990; 228(4): 281-96.
  148. Davidorf F.H., Mouser J.G., Derick R.J. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 2006; 26(3): 354-6.
  149. Iliev M.E., Domig D., Wolf-Schnurrbursch U., Wolf S., Sarra G.M. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006; 142(6): 1054-6.
  150. Oshima Y., Sakaguchi H., Gomi F., Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2006; 142(1): 155-8.
  151. Wakabayashi T., Oshima Y., Sakaguchi H., Ikuno Y., Miki A., Gomi F., et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 2008; 115(9): 1571-80, 80 e1-3.
  152. Bartz-Schmidt K.U., Thumann G., Psichias A., Krieglstein G.K., Heimann K. Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol 1999; 237(12): 969-75.
  153. Flaxel C.J., Larkin G.B., Broadway D.B., Allen P.J., Leaver P.K. Peripheral transscleral retinal diode laser for rubeosis iridis. Retina 1997; 17(5): 421-9.
  154. Olmos L.C., Lee R.K. Medical and surgical treatment of neovascular glaucoma. Int Ophthalmol Clin 2011; 51(3): 27-36.
  155. Shields M.B., Shields S.E. Noncontact transscleral Nd:YAG cyclophotocoagulation: a long-term follow-up of 500 patients. Trans Am Ophthalmol Soc 1994; 92(271-83; discussion 83-7.
  156. Threlkeld A.B., Johnson M.H. Contact transscleral diode cyclophotocoagulation for refractory glaucoma. J Glaucoma 1999; 8(1): 3-7.
  157. Delgado M.F., Dickens C.J., Iwach A.G., Novack G.D., Nychka D.S., Wong P.C., et al. Long-term results of noncontact neodymium:yttrium-aluminum-garnet cyclophotocoagulation in neovascular glaucoma. Ophthalmology 2003; 110(5): 895-9.
  158. Euswas A., Warrasak S. Long-term results of early trabeculectomy with mitomycin-C and subsequent posterior segment intervention in the treatment of neovascular glaucoma with hazy ocular media. J Med Assoc Thai 2005; 88(11): 1582-90.
  159. Kiuchi Y., Sugimoto R., Nakae K., Saito Y., Ito S. Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. Ophthalmologica 2006; 220(6): 383-8.
  160. Mandal A.K., Majji A.B., Mandal S.P., Das T., Jalali S., Gothwal V.K., et al. Mitomycin-C-augmented trabeculectomy for neovascular glaucoma. A preliminary report. Indian J Ophthalmol 2002; 50(4): 287-93.
  161. Allen R.C., Bellows A.R., Hutchinson B.T., Murphy S.D. Filtration surgery in the treatment of neovascular glaucoma. Ophthalmology 1982; 89(10): 1181-7.
  162. Saito Y., Higashide T., Takeda H., Ohkubo S., Sugiyama K. Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmol 2010; 88(1): 96-102.
  163. Mermoud A., Salmon J.F., Alexander P., Straker C., Murray A.D. Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome. Ophthalmology 1993; 100(6): 897-902.
  164. Tsai J.C., Johnson C.C., Dietrich M.S. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison of outcome. Ophthalmology 2003; 110(9): 1814-21.
  165. Netland P.A. The Ahmed glaucoma valve in neovascular glaucoma (An AOS Thesis). Trans Am Ophthalmol Soc 2009; 107(325-42.
  166. Yalvac I.S., Eksioglu U., Satana B., Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye (Lond) 2007; 21(1): 65-70.
  167. Dev S., Damji K.F., DeBacker C.M., Cox T.A., Dutton J.J., Allingham R.R. Decrease in intraocular pressure after orbital decompression for thyroid orbitopathy. Can J Ophthalmol 1998; 33(6): 314-9.
  168. Keltner J.L., Satterfield D., Dublin A.B., Lee B.C. Dural and carotid cavernous sinus fistulas. Diagnosis, management, and complications. Ophthalmology 1987; 94(12): 1585-600.
  169. Goldberg R.A., Goldey S.H., Duckwiler G., Vinuela F. Management of cavernous sinus-dural fistulas. Indications and techniques for primary embolization via the superior ophthalmic vein. Arch Ophthalmol 1996; 114(6): 707-14.
  170. Minas T.F., Podos S.M. Familial glaucoma associated with elevated episcleral venous pressure. Arch Ophthalmol 1968; 80(2): 202-8.
  171. Foroozan R., Buono L.M., Savino P.J., Sergott R.C. Idiopathic dilated episcleral veins and increased intraocular pressure. Br J Ophthalmol 2003; 87(5): 652-4.
  172. Kollarits C.R., Gaasterland D., Di Chiro G., Christiansen J., Yee R.D. Management of a patient with orbital varices, visual loss, and ipsilateral glaucoma. Ophthalmic Surg 1977; 8(5): 54-62.
  173. Ellant J.P., Obstbaum S.A. Lens-induced glaucoma. Doc Ophthalmol 1992; 81(3): 317-38.
  174. Epstein D.L. Diagnosis and management of lens-induced glaucoma. Ophthalmology 1982; 89(3): 227-30.
  175. Papaconstantinou D., Georgalas I., Kourtis N., Krassas A., Diagourtas A., Koutsandrea C., et al. Lens-induced glaucoma in the elderly. Clin Interv Aging 2009; 4(331-6.
  176. Yaakub A., Abdullah N., Siti Raihan I., Ahmad Tajudin L.S. Lens-induced glaucoma in a tertiary centre in northeast of Malaysia. Malays Fam Physician 2014; 9(2): 48-52.
  177. Rodman H.I. Chronic oper-angle glaucoma associated with traumatic dislocation of the lens. A new pathogenetic concept. Arch Ophthalmol 1963; 69(445-54.
  178. Papakostas T.D., Yonekawa Y., Chee Y.E., Qian C.X., Kim I.K. Ultrasonographic biomicroscopy in lens-induced glaucoma. JAMA Ophthalmol 2015; 133(1): 112.
  179. Rohatgi J.N. Lens induced glaucoma. A clinical study. Indian J Ophthalmol 1972; 20(2): 88-93.
  180. Sitoula R.P., Sarkar I., Nayak D., Singh S.K. Lens induced glaucoma: An experience in tertiary eye care center in eastern Nepal. Nepal J Ophthalmol 2016; 8(16): 161-6.
  181. Shrestha R., Godar M.S., Gurung S., Devkota P., Manandhar L.D., Shrestha N. Lens induced glaucoma in a tertiary eye care centre in Western Nepal. Nepal J Ophthalmol 2019; 11(22): 145-51.
  182. Pradhan D., Hennig A., Kumar J., Foster A. A prospective study of 413 cases of lens-induced glaucoma in Nepal. Indian J Ophthalmol 2001; 49(2): 103-7.
  183. Li M., Yan X.Q., Li G.Y., Zhang H. Post-miosis changes in the anterior chamber structures in primary and lens-induced secondary chronic angle-closure glaucoma. Int J Ophthalmol 2019; 12(4): 675-80.
  184. Chandrashekharan S., Chakrabarty S., Tanwar M., Madhuvarasu B., Uduman M.S., Ramakrishnan R. Outcomes and favourable prognostic factors in patients of phacomorphic and phacolytic glaucoma managed by manual small-incision cataract surgery: A retrospective study. Indian J Ophthalmol 2022; 70(4): 1216-21.
  185. Sinha A. Combined trabeculectomy and cataract extraction (in lens induced glaucoma). Indian J Ophthalmol 1983; 31 Suppl(836-8.
  186. Azuara-Blanco A., Burr J., Ramsay C., Cooper D., Foster P.J., Friedman D.S., et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet 2016; 388(10052): 1389-97.
  187. Costa V.P., Leung C.K.S., Kook M.S., Lin S.C., Global Glaucoma A. Clear lens extraction in eyes with primary angle closure and primary angle-closure glaucoma. Surv Ophthalmol 2020; 65(6): 662-74.
  188. Potop V., Corbu C. The role of clear lens extraction in angle closure glaucoma. Rom J Ophthalmol 2017; 61(4): 244-8.
  189. Bogorodzki B., Gralek M. Phacolytic glaucoma as a complication of highly developed cataract. Klin Oczna 1988; 90(12): 422-3.
  190. Cernea P., Nicolescu R. Phacolytic glaucoma. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol 1988; 32(2): 95-100.
  191. Filipe J.C., Palmares J., Delgado L., Lopes J.M., Borges J., Castro-Correia J. Phacolytic glaucoma and lens-induced uveitis. Int Ophthalmol 1993; 17(5): 289-93.
  192. Mavrakanas N., Axmann S., Issum C.V., Schutz J.S., Shaarawy T. Phacolytic glaucoma: are there 2 forms? J Glaucoma 2012; 21(4): 248-9.
  193. Oprescu M. The etiopathology of phacoantigenic uveitis and phacolytic glaucoma. Oftalmologia 1992; 36(3): 207-13.
  194. Seth N.G., Thattaruthody F., Pandav S.S. Phacolytic Glaucoma. Ophthalmol Glaucoma 2019; 2(3): 155.
  195. Shah S.S., Meyer J.J. Lens-Induced Glaucoma. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Jay Meyer declares no relevant financial relationships with ineligible companies.2024.
  196. Sun W.R. Phacolytic glaucoma. Zhonghua Yan Ke Za Zhi 1986; 22(1): 24-6.
  197. Marak G.E., Jr. Phacoanaphylactic endophthalmitis. Surv Ophthalmol 1992; 36(5): 325-39.
  198. Thach A.B., Marak G.E., Jr., McLean I.W., Green W.R. Phacoanaphylactic endophthalmitis: a clinicopathologic review. Int Ophthalmol 1991; 15(4): 271-9.
  199. Hassan N.A., Reddy M.A., Reddy S.S. Late occurrence of lens particle glaucoma due to an occult glass intralenticular foreign body. Middle East Afr J Ophthalmol 2009; 16(2): 97-9.
  200. Jain S.S., Rao P., Nayak P., Kothari K. Posterior capsular dehiscence following blunt injury causing delayed onset lens particle glaucoma. Indian J Ophthalmol 2004; 52(4): 325-7.
  201. Kee C., Lee S. Lens particle glaucoma occurring 15 years after cataract surgery. Korean J Ophthalmol 2001; 15(2): 137-9.
  202. Kim T.H., Kim S.J., Kim E., Chung I.Y., Park J.M., Yoo J.M., et al. Spontaneous anterior lens capsular dehiscence causing lens particle glaucoma. Yonsei Med J 2009; 50(3): 452-4.
  203. Braganza A., Thomas R., George T., Mermoud A. Management of phacolytic glaucoma: experience of 135 cases. Indian J Ophthalmol 1998; 46(3): 139-43.
  204. Mandal A.K., Gothwal V.K. Intraocular pressure control and visual outcome in patients with phacolytic glaucoma managed by extracapsular cataract extraction with or without posterior chamber intraocular lens implantation. Ophthalmic Surg Lasers 1998; 29(11): 880-9.
  205. Venkatesh R., Tan C.S., Kumar T.T., Ravindran R.D. Safety and efficacy of manual small incision cataract surgery for phacolytic glaucoma. Br J Ophthalmol 2007; 91(3): 279-81.
  206. Apple D.J., Mamalis N., Steinmetz R.L., Loftfield K., Crandall A.S., Olson R.J. Phacoanaphylactic endophthalmitis associated with extracapsular cataract extraction and posterior chamber intraocular lens. Arch Ophthalmol 1984; 102(10): 1528-32.
  207. Kersey J.P., Broadway D.C. Corticosteroid-induced glaucoma: a review of the literature. Eye (Lond) 2006; 20(4): 407-16.
  208. Saadat F., Raji A., Zomorodian K., Eslami M.B., Pezeshki M., Khorramizadeh M.R., et al. Alteration in Matrix Metalloproteinases (MMPS) Activity in Fibroblast Cell Line by Dexamethasone: A Possible Mechanism in Corticosteroid-Induced Glaucoma. Iran J Allergy Asthma Immunol 2003; 2(3): 145-8.
  209. Siliato F. Pathogenesis of corticosteroid-induced glaucoma. Minerva Oftalmol 1969; 11(5): 160-3.
  210. Armaly M.F. Effect of Corticosteroids on Intraocular Pressure and Fluid Dynamics. I. The Effect of Dexamethasone in the Normal Eye. Arch Ophthalmol 1963; 70(482-91.
  211. Armaly M.F. Effect of Corticosteroids on Intraocular Pressure and Fluid Dynamics. Ii. The Effect of Dexamethasone in the Glaucomatous Eye. Arch Ophthalmol 1963; 70(492-9.
  212. Jones R., 3rd, Rhee D.J. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 2006; 17(2): 163-7.
  213. Lam D.S., Fan D.S., Ng J.S., Yu C.B., Wong C.Y., Cheung A.Y. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial. Clin Exp Ophthalmol 2005; 33(3): 252-8.
  214. Becker B., Hahn K.A. Topical Corticosteroids and Heredity in Primary Open-Angle Glaucoma. Am J Ophthalmol 1964; 57(543-51.
  215. Cantrill H.L., Palmberg P.F., Zink H.A., Waltman S.R., Podos S.M., Becker B. Comparison of in vitro potency of corticosteroids with ability to raise intraocular pressure. Am J Ophthalmol 1975; 79(6): 1012-7.
  216. Urban R.C., Jr., Dreyer E.B. Corticosteroid-induced glaucoma. Int Ophthalmol Clin 1993; 33(2): 135-9.
  217. Panda A., Sood N.N., Agarwal L.P. Corticosteroid induced glaucoma and cataract. Indian J Ophthalmol 1981; 29(4): 377-9.
  218. Spaeth G.L., Monteiro de Barros D.S., Fudemberg S.J. Visual loss caused by corticosteroid-induced glaucoma: how to avoid it. Retina 2009; 29(8): 1057-61.
  219. Smithen L.M., Ober M.D., Maranan L., Spaide R.F. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 2004; 138(5): 740-3.
  220. AlObaida I., Al Owaifeer A.M., Alotaibi H., Alsafi A., Ali Aljasim L. Outcomes of selective laser trabeculoplasty in corticosteroid-induced ocular hypertension and glaucoma. Eur J Ophthalmol 2022; 32(3): 1525-9.
  221. Kawabe A., Uesawa Y. Analysis of Corticosteroid-Induced Glaucoma Using the Japanese Adverse Drug Event Reporting Database. Pharmaceuticals (Basel) 2023; 16(7).
  222. Scruggs D., Scruggs R., Stukenborg G., Netland P.A., Calland J.F. Ocular injuries in trauma patients: an analysis of 28,340 trauma admissions in the 2003-2007 National Trauma Data Bank National Sample Program. J Trauma Acute Care Surg 2012; 73(5): 1308-12.
  223. Wong T.Y., Klein B.E., Klein R. The prevalence and 5-year incidence of ocular trauma. The Beaver Dam Eye Study. Ophthalmology 2000; 107(12): 2196-202.
  224. De Leon-Ortega J.E., Girkin C.A. Ocular trauma-related glaucoma. Ophthalmol Clin North Am 2002; 15(2): 215-23.
  225. Girkin C.A., McGwin G., Jr., Morris R., Kuhn F. Glaucoma following penetrating ocular trauma: a cohort study of the United States Eye Injury Registry. Am J Ophthalmol 2005; 139(1): 100-5.
  226. May D.R., Kuhn F.P., Morris R.E., Witherspoon C.D., Danis R.P., Matthews G.P., et al. The epidemiology of serious eye injuries from the United States Eye Injury Registry. Graefes Arch Clin Exp Ophthalmol 2000; 238(2): 153-7.
  227. Canavan Y.M., Archer D.B. Anterior segment consequences of blunt ocular injury. Br J Ophthalmol 1982; 66(9): 549-55.
  228. Klopfer J., Tielsch J.M., Vitale S., See L.C., Canner J.K. Ocular trauma in the United States. Eye injuries resulting in hospitalization, 1984 through 1987. Arch Ophthalmol 1992; 110(6): 838-42.
  229. Lesher M.P., Durrie D.S., Stiles M.C. Corneal edema, hyphema, and angle recession after air bag inflation. Arch Ophthalmol 1993; 111(10): 1320-2.
  230. Campbell D. Traumatic glaucoma. In: Shingleton BJ, Hersh PJ, Kenyon KR, editor. Textbook of Glaucoma. St. Louis: Mosby Year Book; 1991.
  231. Coles W.H. Traumatic hyphema: an analysis of 235 cases. South Med J 1968; 61(8): 813-6.
  232. Brandt M.T., Haug R.H. Traumatic hyphema: a comprehensive review. J Oral Maxillofac Surg 2001; 59(12): 1462-70.
  233. Sihota R., Sood N.N., Agarwal H.C. Traumatic glaucoma. Acta Ophthalmol Scand 1995; 73(3): 252-4.
  234. Mansouri K., Sommerhalder J., Shaarawy T. Prospective comparison of ultrasound biomicroscopy and anterior segment optical coherence tomography for evaluation of anterior chamber dimensions in European eyes with primary angle closure. Eye (Lond) 2010; 24(2): 233-9.
  235. Crouch E.R., Jr., Crouch E.R. Management of traumatic hyphema: therapeutic options. J Pediatr Ophthalmol Strabismus 1999; 36(5): 238-50; quiz 79-80.
  236. Shiuey Y., Lucarelli M.J. Traumatic hyphema: outcomes of outpatient management. Ophthalmology 1998; 105(5): 851-5.
  237. Ulagantheran V., Ahmad Fauzi M.S., Reddy S.C. Hyphema due to blunt injury: a review of 118 patients. Int J Ophthalmol 2010; 3(3): 272-6.
  238. Sankar P.S., Chen T.C., Grosskreutz C.L., Pasquale L.R. Traumatic hyphema. Int Ophthalmol Clin 2002; 42(3): 57-68.
  239. Walton W., Von Hagen S., Grigorian R., Zarbin M. Management of traumatic hyphema. Surv Ophthalmol 2002; 47(4): 297-334.
  240. Bai H.Q., Yao L., Wang D.B., Jin R., Wang Y.X. Causes and treatments of traumatic secondary glaucoma. Eur J Ophthalmol 2009; 19(2): 201-6.
  241. Fong L.P. Secondary hemorrhage in traumatic hyphema. Predictive factors for selective prophylaxis. Ophthalmology 1994; 101(9): 1583-8.
  242. Romano P.E., Robinson J.A. Traumatic hyphema: a comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (P<.0001). Binocul Vis Strabismus Q 2000; 15(2): 175-86.
  243. Rahmani B., Jahadi H.R. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial. Ophthalmology 1999; 106(2): 375-9.
  244. Kaufman J.H., Tolpin D.W. Glaucoma after traumatic angle recession. A ten-year prospective study. Am J Ophthalmol 1974; 78(4): 648-54.
  245. Mooney D. Angle recession and secondary glaucoma. Br J Ophthalmol 1973; 57(8): 608-12.
  246. Sihota R., Kumar S., Gupta V., Dada T., Kashyap S., Insan R., et al. Early predictors of traumatic glaucoma after closed globe injury: trabecular pigmentation, widened angle recess, and higher baseline intraocular pressure. Arch Ophthalmol 2008; 126(7): 921-6.
  247. Cameron J.D., Havener V.R. Histologic confirmation of ghost cell glaucoma by routine light microscopy. Am J Ophthalmol 1983; 96(2): 251-2.
  248. Campbell D.G. Ghost cell glaucoma following trauma. Ophthalmology 1981; 88(11): 1151-8.
  249. Campbell D.G., Essigmann E.M. Hemolytic ghost cell glaucoma. Further studies. Arch Ophthalmol 1979; 97(11): 2141-6.
  250. de Keizer R.J., Hogeweg M. Ghost cell glaucoma. Fortschr Ophthalmol 1987; 84(3): 249-51.
  251. Li Z.H. Ghost cell glaucoma. Zhonghua Yan Ke Za Zhi 1984; 20(1): 23-5.
  252. Montenegro M.H., Simmons R.J. Ghost cell glaucoma. Int Ophthalmol Clin 1995; 35(1): 111-5.
  253. Ritch R., Richardson T., Liebmann J. Ghost cell glaucoma. J Glaucoma 1994; 3(4): 333-8.
  254. Rojas L., Ortiz G., Gutierrez M., Corredor S. Ghost cell glaucoma related to snake poisoning. Arch Ophthalmol 2001; 119(8): 1212-3.
  255. Thomas R., Alexander T.A., Joseph P., Sajeev G. Ghost cell glaucoma. Indian J Ophthalmol 1985; 33(1): 53-5.
  256. Masket S., Ceran B.B. Atypical case of ocular hemosiderosis: leopard cataract. J Cataract Refract Surg 2011; 37(10): 1902-4.
  257. Schechner R., Miller B., Merksamer E., Perlman I. A long term follow up of ocular siderosis: quantitative assessment of the electroretinogram. Doc Ophthalmol 1990; 76(3): 231-40.
  258. Vannas S. Hemosiderosis in eyes with secondary glaucoma after delayed intraocular hemorrhages. Acta Ophthalmol (Copenh) 1960; 38(254-67.
  259. Phelps C.D., Watzke R.C. Hemolytic glaucoma. Am J Ophthalmol 1975; 80(4): 690-5.
  260. Manners T., Salmon J.F., Barron A., Willies C., Murray A.D. Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma. Br J Ophthalmol 2001; 85(2): 159-63.
  261. Mermoud A., Salmon J.F., Barron A., Straker C., Murray A.D. Surgical management of post-traumatic angle recession glaucoma. Ophthalmology 1993; 100(5): 634-42.
  262. Almodovar-Mercado J.C., Lopez-Beauchamp V. Penetrating eye globe injury from trauma with a metallic nail: a case report. Bol Asoc Med P R 2013; 105(2): 59-61.
  263. Dannenberg A.L., Parver L.M., Fowler C.J. Penetrating eye injuries related to assault. The National Eye Trauma System Registry. Arch Ophthalmol 1992; 110(6): 849-52.
  264. Landolfi M., Bhagat N., Langer P., Rescigno R., Mirani N., Gass J.D., et al. Penetrating trauma associated with findings of multiple evanescent white dot syndrome in the second eye: coincidence or an atypical case of sympathetic ophthalmia? Retina 2004; 24(4): 637-45.
  265. Fernandez-Ferro M., Fernandez-Fernandez M., Fernandez-Sanroman J., Costas-Lopez A., Lopez-Betancourt A. Management of a Penetrating Orbital Trauma from an Unusual Foreign Body with Associated Eye Injury. Ann Maxillofac Surg 2019; 9(1): 214-7.
  266. Ramdas W.D. The relation between dietary intake and glaucoma: a systematic review. Acta Ophthalmol 2018; 96(6): 550-6.
  267. Ali M., Akhtar F. Ocular digital massage for the management of post- trabeculectomy underfiltering blebs. J Coll Physicians Surg Pak 2011; 21(11): 676-9.
  268. Антонов П.Ф., Ситников О.В., Цырулина Д.Р., Мареева Г.И. Эффективность санаторно-курортного лечения больных с глаукомой на низкогорном климатическом курорте. Военно-медицинский журнал 2020; 341(4): 69-71.
  269. Kothari R., Tathe S., Gogri P., Bhandari A. Lens-Induced Glaucoma: The need to spread awareness about early management of cataract among rural population. ISRN Ophthalmol. 2013:581727.
  270. Selbach J.M., Posielek K., Steuhl K.P. et al. Episcleral venous pressure in untreated primary open-angle and normal-tension glaucoma. Ophthalmologica 2005; 219(6): 357-61.
  271. Клинические рекомендации «Увеиты неинфекционные» 2024 (12.07.2024), Утверждены Минздравом РФ.]
  272. Breusegem C., Spielberg L., Van Ginderdeuren R., Vandewalle E., Renier C., Van de Veire S., et al. Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial. Ophthalmology. 2010; 117(7): 1324-1330.
  273. Mastropasqua L., Brescia L., D'Arcangelo F., Nubile M., D'Onofrio G., Totta M., et al. Topical Steroids and Glaucoma Filtration Surgery Outcomes: An In Vivo Confocal Study of the Conjunctiva. J Clin Med. 2022; 11(14).
  274. Lee S.J., Paranhos A., Shields M.B. Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome? Clin Ophthalmol. 2009; 3:81-87.
  275. Bettin P., Khaw P.T. Glaucoma surgery. S. Karger AG, Basel (Switzerland). 2012. p. 188
  276. Ahmadzadeh A., Kessel L., Schmidt B.S., Kolko M., Bach-Holm D. Steroids and/or non-steroidal anti-inflammatory drugs as postoperative treatment after trabeculectomy-12-month results of a randomized controlled trial. J Clin Med. 2024; 13(3).
  277. Panarelli J.F., Nayak N.V., Sidoti P.A. Postoperative management of trabeculectomy and glaucoma drainage implant surgery. Curr Opin Ophthalmol. 2016; 27(2): 170-176.
  278. Starita R.J., Fellman R.L., Spaeth G.L., Poryzees E.M., Greenidge K.C., Traverso C.E. Short- and long-term effects of postoperative corticosteroids on trabeculectomy. Ophthalmology. 1985; 92(7): 938-946.
  279. Фролов М.А. Дренажная хирургия глаукомы. Москва: ГЭОТАР-Медиа, 2024.
  280. Ченцова О.Б., Харченко Л.Н., Усова Л.А. Вторичная глаукома. Клиника, диагностика, лечение. Учебное пособие. Москва, 2014, 20 с.
  281. Травмы глаз / Р.А. Гундорова, В.В. Нероев, В.В. Кашников. – М.: Издательство Гэотар-Медиа, 2009. – 553 с.
  282. Сусайкова, М.С. Особенности клиники, диагностики и лечения больных с травмой глаза на этапе неотложной специализированной помощи. / Автореферат диссертации канд. мед. наук: 14.00.08 / Московский НИИ глазных болезней им. Гельмгольца – М., – 2005. – С. 24.
  283. Планы ведения больных «Офтальмология» Доказательная медицина / Атьков О.Ю., Леонова Е.С. – М.: Издательство Гэотар-Медиа, 2011, – С. 83-99.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*